Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164176768> ?p ?o ?g. }
- W3164176768 endingPage "835" @default.
- W3164176768 startingPage "827" @default.
- W3164176768 abstract "Abstract In chronic lymphocytic leukemia (CLL), increasing knowledge of the biology of the tumor cells has led to transformative improvements in our capacity to assess and treat patients. The dependence of tumor cells on surface immunoglobulin receptor signaling, survival pathways, and accessory cells within the microenvironment has led to a successful double-barreled attack with designer drugs. Studies have revealed that CLL should be classified based on the mutational status of the expressed IGHV sequences into 2 diseases, either unmutated (U) or mutated (M) CLL, each with a distinctive cellular origin, biology, epigenetics/genetics, and clinical behavior. The origin of U-CLL lies among the natural antibody repertoire, and dominance of IGHV1-69 reveals a superantigenic driver. In both U-CLL and M-CLL, a calibrated stimulation of tumor cells by self-antigens apparently generates a dynamic reiterative cycle as cells, protected from apoptosis, transit between blood and tissue sites. But there are differences in outcome, with the balance between proliferation and anergy favoring anergy in M-CLL. Responses are modulated by an array of microenvironmental interactions. Availability of T-cell help is a likely determinant of cell fate, the dependency on which varies between U-CLL and M-CLL, reflecting the different cells of origin, and affecting clinical behavior. Despite such advances, cell-escape strategies, Richter transformation, and immunosuppression remain as challenges, which only may be met by continued research into the biology of CLL." @default.
- W3164176768 created "2021-06-07" @default.
- W3164176768 creator A5036828560 @default.
- W3164176768 creator A5047140412 @default.
- W3164176768 creator A5078295579 @default.
- W3164176768 date "2021-06-01" @default.
- W3164176768 modified "2023-10-16" @default.
- W3164176768 title "Exploring the pathways to chronic lymphocytic leukemia" @default.
- W3164176768 cites W115619992 @default.
- W3164176768 cites W1243376384 @default.
- W3164176768 cites W1429374962 @default.
- W3164176768 cites W1531083786 @default.
- W3164176768 cites W1542899169 @default.
- W3164176768 cites W1851200632 @default.
- W3164176768 cites W1930648416 @default.
- W3164176768 cites W1966460887 @default.
- W3164176768 cites W1971100070 @default.
- W3164176768 cites W1971818445 @default.
- W3164176768 cites W1973910208 @default.
- W3164176768 cites W1975673932 @default.
- W3164176768 cites W1978738634 @default.
- W3164176768 cites W1985563073 @default.
- W3164176768 cites W1990159135 @default.
- W3164176768 cites W1990986028 @default.
- W3164176768 cites W2002404007 @default.
- W3164176768 cites W2005150159 @default.
- W3164176768 cites W2010811029 @default.
- W3164176768 cites W2016191976 @default.
- W3164176768 cites W2019655196 @default.
- W3164176768 cites W2023192965 @default.
- W3164176768 cites W2026479790 @default.
- W3164176768 cites W2027774059 @default.
- W3164176768 cites W2039151199 @default.
- W3164176768 cites W2041309682 @default.
- W3164176768 cites W2056807976 @default.
- W3164176768 cites W2058322736 @default.
- W3164176768 cites W2058786179 @default.
- W3164176768 cites W2058949669 @default.
- W3164176768 cites W2060013333 @default.
- W3164176768 cites W2064381013 @default.
- W3164176768 cites W2064583052 @default.
- W3164176768 cites W2065338378 @default.
- W3164176768 cites W2066030565 @default.
- W3164176768 cites W2067064694 @default.
- W3164176768 cites W2068868786 @default.
- W3164176768 cites W2074677800 @default.
- W3164176768 cites W2075901113 @default.
- W3164176768 cites W2077573001 @default.
- W3164176768 cites W2083722330 @default.
- W3164176768 cites W2085526819 @default.
- W3164176768 cites W2088373095 @default.
- W3164176768 cites W2091664866 @default.
- W3164176768 cites W2095130722 @default.
- W3164176768 cites W2097290512 @default.
- W3164176768 cites W2097521725 @default.
- W3164176768 cites W2099468505 @default.
- W3164176768 cites W2105655824 @default.
- W3164176768 cites W2106248009 @default.
- W3164176768 cites W2108374688 @default.
- W3164176768 cites W2111609050 @default.
- W3164176768 cites W2113475715 @default.
- W3164176768 cites W2114003068 @default.
- W3164176768 cites W2119572797 @default.
- W3164176768 cites W2134811927 @default.
- W3164176768 cites W2135314242 @default.
- W3164176768 cites W2135387211 @default.
- W3164176768 cites W2136272158 @default.
- W3164176768 cites W2137144638 @default.
- W3164176768 cites W2140821709 @default.
- W3164176768 cites W2142160913 @default.
- W3164176768 cites W2150013151 @default.
- W3164176768 cites W2157274762 @default.
- W3164176768 cites W2162106495 @default.
- W3164176768 cites W2164503950 @default.
- W3164176768 cites W2172019913 @default.
- W3164176768 cites W2201487045 @default.
- W3164176768 cites W2204986825 @default.
- W3164176768 cites W2210752542 @default.
- W3164176768 cites W2275847773 @default.
- W3164176768 cites W2278193989 @default.
- W3164176768 cites W2287299074 @default.
- W3164176768 cites W2294814189 @default.
- W3164176768 cites W2316244721 @default.
- W3164176768 cites W2316589011 @default.
- W3164176768 cites W2403449504 @default.
- W3164176768 cites W2408036343 @default.
- W3164176768 cites W2428539785 @default.
- W3164176768 cites W2482579995 @default.
- W3164176768 cites W2547412310 @default.
- W3164176768 cites W2558290791 @default.
- W3164176768 cites W2611877356 @default.
- W3164176768 cites W2623503441 @default.
- W3164176768 cites W2769052922 @default.
- W3164176768 cites W2772944212 @default.
- W3164176768 cites W2775157068 @default.
- W3164176768 cites W2804868427 @default.
- W3164176768 cites W28190658 @default.
- W3164176768 cites W2899403225 @default.